Drugs Index
Medical Conditions:
- Medical Conditions G
- Medical Conditions I
- Medical Conditions P
- Medical Conditions C
- Medical Conditions N
- Medical Conditions T
- Medical Conditions E
- Medical Conditions D
- Medical Conditions F
- Medical Conditions H
- Medical Conditions M
- Medical Conditions B
- Medical Conditions U
- Medical Conditions O
- Medical Conditions S
- Medical Conditions A
- Medical Conditions R
- Medical Conditions L
- Medical Conditions W
- Medical Conditions V
- Medical Conditions K
- Medical Conditions J
- Medical Conditions X
Drug Classes
- Drug Classes A
- Drug Classes M
- Drug Classes H
- Drug Classes C
- Drug Classes B
- Drug Classes U
- Drug Classes T
- Drug Classes O
- Drug Classes I
- Drug Classes N
- Drug Classes V
- Drug Classes E
- Drug Classes G
- Drug Classes P
- Drug Classes L
- Drug Classes Q
- Drug Classes F
- Drug Classes S
- Drug Classes D
- Drug Classes R
- Drug Classes 5
- Drug Classes K
Drugs Information:
Drugs List
Isosorbide Mononitrate Tablets 10mg, 20mg and 40mg
- Please read this leaflet carefully before you start to take your medicine.
- It tells you some of the more important things you should know.
- If you want to know more, or you are not sure about anything, ask your doctor or pharmacist.
What’S In Your Medicine
Isosorbide Mononitrate Tablets are circular white to off-white uncoated tablets which come in three strengths, containing 10mg; 20mg; or 40mg of the active ingredient isosorbide mononitrate.
They also contain: lactose magnesium stearate, maize starch, polyvidone; E460 (10mg and 40mg only)
Isosorbide Mononitrate Tablets are available in pack sizes of 56s.
Isosorbide mononitrate is one of a group of medicines called nitrate vasodilators. These drugs relax the muscle layer in the blood vessel wall of the heart. This reduces strain on the heart by making it easier to pump blood.
MA holder/Manufacturer:
About Your Medicine
The name of your medicine is Isosorbide mononitrate which is the generic (common) name. Your doctor may have given you this medicine before from another company and it may have looked slightly different. Either brand will have the same effect.
Isosorbide Mononitrate Tablets ar
1. Name Of The Medicinal Product
innohep® 20,000 IU/ml and innohep® Syringe 20,000 IU/ml
2. Qualitative And Quantitative Composition
Tinzaparin sodium 20,000 anti-Factor Xa IU/ml
3. Pharmaceutical Form
Solution for injection
4. Clinical Particulars
4.1 Therapeutic Indications
Treatment of deep vein thrombosis and of pulmonary embolus.
4.2 Posology And Method Of Administration
Administration is by subcutaneous injection only.
Adults:
175 anti-Factor Xa IU/kg bodyweight once daily, for at least 6 days and until adequate oral anti-coagulation is established. There is no need to monitor the anticoagulant activity of innohep®.
Patients with renal impairment:
Caution is recommended when treating patients with renal impairment (see Section 4.4, Special warnings and precautions for use). Monitoring of anti-factor Xa activity should be considered in patients with severe renal impairment (creatinine clearance < 30 ml/min); however, available evidence suggests that no dose reduction is needed in patients with creatinine clearance levels down to 20 ml/min.
Elderly:
Renal function should be assessed, for example with the Cockcroft-Gault formula, to estimate creatinine clearance levels. No dose reduction is needed in elderly patients with normal renal function (see Section 4.4, Special warnings and precautions for use).
Children:
There is no experience of use in children.
4.3 Contraindi
1. Name Of The Medicinal Product
IMODIUM PLUS CAPLET
2. Qualitative And Quantitative Composition
Each tablet contains loperamide hydrochloride 2 mg and simeticone equivalent to 125 mg dimeticone.
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Tablet, uncoated
White, capsule-shaped tablets debossed with “IMO” on one side, the other side is debossed with a line between “2”and “125”.
4. Clinical Particulars
4.1 Therapeutic Indications
Imodium Plus Caplets are indicated for the symptomatic treatment of acute diarrhoea in adults and adolescents over 12 years when acute diarrhoea is associated with gas-related abdominal discomfort including bloating, cramping or flatulence.
4.2 Posology And Method Of Administration
The tablets should be taken with liquid.
Adults over 18 years:
Take two caplets initially, followed by one caplet after every loose stool. Not more than 4 caplets should be taken in a day, limited to no more than 2 days.
Adolescents between 12 and 18 years:
Take one caplet initially, followed by one caplet after every loose stool. Not more than 4 caplets should be taken in a day, limited to no more than 2 days.
Use in children:
Imodium Plus must not be used in children under 12 years.
Use in the elderly:
No dosage adjustments are required for the elderly.
Use in renal impairment:
No dosage adjustment
1. Name Of The Medicinal Product
Implanon®, 68 mg implant for subdermal use
2. Qualitative And Quantitative Composition
One implant contains 68 mg of etonogestrel; the release rate is approximately 60-70 µg/day in week 5-6 and has decreased to approximately 35-45 µg/day at the end of the first year, to approximately 30-40 µg/day at the end of the second year and to approximately 25-30 µg/day at the end of the third year.
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Implant for subdermal use
Non-biodegradable white to off-white flexible rod.
4. Clinical Particulars
4.1 Therapeutic Indications
Contraception.
Safety and efficacy have been established in women between 18 and 40 years of age.
4.2 Posology And Method Of Administration
4.2.1 How to use Implanon
Pregnancy should be excluded before insertion of Implanon.
Prior to inserting Implanon it is strongly recommended to carefully read the instructions for insertion and removal of the implant in section 4.2.2 “How to insert Implanon” and section 4.2.4 “How to remove Implanon”.
Implanon is a long-acting contraceptive. One implant is inserted subdermally. The user should be informed that she can request the removal of Implanon at any time but the implant should not be left in place more than three years. Clinicians may consider earlier replacement of the implant in heavier women (see section 4.4.1). Only a physician who is familiar with the removal technique should perform, on request or at the end of the 3 years of use, the removal of Implanon. After the removal of the implant, immediate insertion of another impl
increlex
10 mg/ml solution for injection
mecasermin
Read all of this leaflet carefully before you start using this medicine.
- Keep this leaflet. You may need to read it again.
- If you have further questions, please ask the doctor or pharmacist.
- This medicine has been prescribed for you/your child. Do not pass it on to others. It may harm them, even if their symptoms are the same.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell the doctor or pharmacist.
In this leaflet:
- 1. What INCRELEX is and what it is used for
- 2. Before you use INCRELEX
- 3. How to use INCRELEX
- 4. Possible side effects
- 5. How to store INCRELEX
- 6. Further information
What Increlex Is And What It Is Used For
- INCRELEX is a liquid that contains man-made insulin-like growth factor-1 (IGF-1), which is similar to the IGF-1 made by your body.
- INCRELEX is used to treat children or adolescents who are very short for their age because their bodies do not make enough IGF-1. This condition is called primary IGF-1 deficiency.
Before You Use Increlex
Do not use INCRELEX
- if you/your child is allergic (hypersensitive) to mecasermin or any of the other ingredients of INCRELEX.
- if you/your child has cancer.
- by inject
1. Name Of The Medicinal Product
IBUGEL™
2. Qualitative And Quantitative Composition
Ibuprofen 5.0% w/w.
3. Pharmaceutical Form
Non-greasy, fragrance-free, clear, aqueous-alcoholic gel.
4. Clinical Particulars
4.1 Therapeutic Indications
For the topical treatment of backache, rheumatic and muscular pain, sprains, strains and neuralgia. Ibugel is also indicated for symptomatic relief of pain due to non-serious arthritic conditions.
4.2 Posology And Method Of Administration
Apply the gel to the affected areas, up to three times daily, or as directed by the physician. On each occasion apply only enough gel to thinly cover the affected area, and gently massage well into the skin, until completely absorbed. Do not use excessively. Hands should be washed immediately after use (unless treating them). Treatment should not normally continue for more than a few weeks, unless recommended to do so by a doctor.
The same dosage and dosage schedule applies to all age groups, although Ibugel is not normally recommended for use on children under the age of 12 years, unless instructed by their doctor.
4.3 Contraindications
Not to be used in cases of sensitivity to any of the ingredients, particularly if asthmatic or suffer from allergic disease, and have previously shown hypersensitivity to aspirin, ibuprofen or related painkillers. Not to be used on broken skin.
4.4 Special Warnings And Precautions For Use
Seek medical advice if symptoms worsen or persist. Oral NSAIDs, including ibuprofen, can sometimes be associated with renal impairment, aggravation of active peptic ulcers, and can induce allergic bronchial reactions in susceptible asthmatic patients. Although the systemic a
1. Name Of The Medicinal Product
Ibuprofen 200mg Soft Gelatine Capsules
2. Qualitative And Quantitative Composition
Ibuprofen 200 mg per capsule, soft.
For excipients see 6.1.
3. Pharmaceutical Form
Capsule, soft
Oval clear capsules printed with a logo in white.
4. Clinical Particulars
4.1 Therapeutic Indications
For the relief of rheumatic or muscular pain, backache, neuralgia, migraine, headache, dental pain, dysmenorrhoea, feverishness, symptoms of colds and influenza.
4.2 Posology And Method Of Administration
For oral administration and short-term use only. Do not chew.
Adults, the elderly and children over 12 years:
The lowest effective dose should be used for the shortest duration necessary to relieve symptoms. The patient should consult a doctor if symptoms persist or worsen, or if the product is required for more than 10 days.
Take one or two capsules (200 mg – 400 mg), up to three times a day as required (maximum dose 400 mg).
Leave at least four hours between doses and do not take more than 6 capsules (1200 mg) in any 24 hour period.
Children under 12 years:
Not recommended.
4.3 Contraindications
Hypersensitivity to ibuprofen or any of the excipients in the product.
Patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to aspirin or other non-steroidal anti-inflammatory drugs.
Active or history of recurrent peptic ulcer / haemorrhage (two or more distinct episodes of proven ulceration or bleeding).
Indometacin Suppositories 100mg
- Please read this leaflet carefully before you start to take your medicine.
- It gives you important information about your medicine.
- If you want to know more, or you are not sure about anything, ask your pharmacist or doctor.
- Keep the leaflet until you have finished the medicine.
What’S In Your Medicine
The active ingredient in this medicine is Indometacin. This is the new name for Indomethacin. The ingredient itself has not changed.
Indometacin Suppositories come in one strength and are yellow. Each suppository contains 100mg of Indometacin and vegetable fat.
Indometacin Suppositories are available in pack sizes of 10s. Your suppositories are made by
who are also the Marketing Authorisation holder.
About Your Medicine
Indometacin is one of a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
These medicines are pain killers which reduce swelling.
Indometacin Suppositories may be used for:
- inflammatory diseases of the joints or surrounding tissue such as rheumatoid arthritis, osteoarthritis and degenerative hip disease
- deformity and stiffening of the backbone (ankylosing spondylitis)
- muscular pain, low back pain and pain following bone or joint surgery
- period pain
- gout.
Before Using Your Medicine
Do not
1. Name Of The Medicinal Product
Irinotecan Actavis 20mg/ml concentrate for solution for infusion
2. Qualitative And Quantitative Composition
One ml of concentrate contains 20mg irinotecan hydrochloride trihydrate equivalent to 17.33 mg/ml irinotecan. Each 2ml, 5ml, 15ml or 25ml vial of irinotecan Actavis contains 40mg, 100mg, 300mg or 500mg of irinotecan hydrochloride trihydrate respectively.
Excipients:
Sorbitol E420
Sodium
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Concentrate for solution for infusion:
A clear, colourless to slightly yellow solution.
4. Clinical Particulars
4.1 Therapeutic Indications
Irinotecan Actavis is indicated for the treatment of patients with advanced colorectal cancer:
- in combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for advanced disease,
- as a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen.
Irinotecan in combination with cetuximab is indicated for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing metastatic colorectal cancer after failure of irinotecan-including cytotoxic therapy.
Irinotecan in combination with 5-fluorouracil, folinic acid and bevacizumab is indicated for first-line treatment of patients with metastatic carcinoma of the colon or rectum.
4.2 Posology And Method Of Administration
For adults only. After dilution Irinotecan Actavis solution for infusion should be infused into a peripheral or central vein.
Recommended dosage
1. Name Of The Medicinal Product
2. Qualitative And Quantitative Composition
One vial contains 150 mg of canakinumab*.
After reconstitution, each ml of solution contains 150 mg canakinumab.
* fully human monoclonal antibody produced in mouse hybridoma Sp2/0 cells by recombinant DNA technology
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Powder for solution for injection.
The powder is white.
4. Clinical Particulars
4.1 Therapeutic Indications
Ilaris is indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) in adults, adolescents and children aged 4 years and older with body weight above 15 kg, including:
? Muckle-Wells Syndrome (MWS),
? Neonatal-Onset Multisystem Inflammatory Disease (NOMID) / Chronic Infantile Neurological, Cutaneous, Articular Syndrome (CINCA),
? Severe forms of Familial Cold Autoinflammatory Syndrome (FCAS) / Familial Cold Urticaria (FCU) presenting with signs and symptoms beyond cold-induced urticarial skin rash.
4.2 Posology And Method Of Administration
Treatment should be initiated and supervised by a specialist physician experienced in the diagnosis and treatment of CAPS.
After proper training in the correct injection technique, patients may self-inject Ilaris if their physician determines that it is appropriate and with medical follow-up as necessary.
Adults, adolescents and children aged 4 years and older
The recommended dose of Ilaris is 150 mg for CAPS patients with body weight > 40 kg and 2 mg/kg for CAPS patients with body weight
If a satisfactory clini
1. Name Of The Medicinal Product
Imigran Radis 50mg Tablets
Imigran Radis 100mg Tablets
2. Qualitative And Quantitative Composition
50mg sumatriptan base as the succinate salt.
100mg sumatriptan base as the succinate salt.
3. Pharmaceutical Form
Film-coated dispersible tablet
Pink film-coated, triangular shaped, biconvex tablets debossed with 'GS 1YM' on one face and '50' on the other.
White film-coated, triangular shaped, biconvex tablets debossed with 'GS YE7' on one face and '100' on the other.
4. Clinical Particulars
4.1 Therapeutic Indications
Imigran Radis tablets are indicated for the acute relief of migraine attacks, with or without aura. Imigran should only be used where there is a clear diagnosis of migraine.
4.2 Posology And Method Of Administration
Adults
Imigran Radis is indicated for the acute intermittent treatment of migraine. It should not be used prophylactically.
It is advisable that Imigran be given as early as possible after the onset of migraine attack but it is equally effective at whatever stage of the attack it is administered.
The recommended dose of oral Imigran is a single 50mg tablet. Some patients may require 100mg. If the patient has responded to the first dose but the symptoms recur a second dose may be given in the next 24 hours provided that there is a minimum interval of two hours between the two doses and no more than 300mg is taken in any 24 hour period.
Patients who do not respond to the prescribed dose of Imigran Radis should not take a second dose for the same attack. Imigran Radis may be taken for subsequent attacks.
Boots Ibuprofen Caplets 200 mg
Read all of this leaflet carefully because it contains important information for you.
This medicine is available without prescription to treat minor conditions. However, you still need to take it carefully to get the best results from it.
- Keep this leaflet, you may need to read it again
- Ask your pharmacist if you need more information or advice
What this medicine is for
This medicine contains ibuprofen which belongs to a group called non-steroidal anti-inflammatory medicines, which act to relieve pain and reduce swelling. It can be used to relieve headaches, rheumatic and muscular pain, backache, migraine, period pain, dental pain and neuralgia. It can also be used to reduce fever and relieve the symptoms of colds and flu.
Before you take this medicine
This medicine can be taken by adults and children aged 12 years and over. However, some people should not take this medicine or should seek the advice of their pharmacist or doctor first.
Do not take:
- If you have a stomach ulcer, perforation or bleeding, or have had one twice or more in the past
- If you have had perforation or a bleeding stomach after taking a non-steroidal anti-inflammatory medicine (you may have been sick and it contained blood or dark particles that look like coffee grounds, passed blood in your stools or passed black tarry stools)
- If you are allergic to ibuprofen or any other ingredients of the product, aspirin or other non-steroidal anti-inflammatory medi
1. Name Of The Medicinal Product
Imipramine Hydrochloride 25mg/5ml Oral Solution
2. Qualitative And Quantitative Composition
Imipramine hydrochloride (N-(?-dimethylaminopropyl)-iminodibenzyl hydrochloride) 25mg / 5ml in an oral solution formulation
Each 5ml of solution also contains;
|
Sorbitol (E420) |
1500.0 mg |
|
|
Methylhydroxy benzoate (E218) |
6.85 mg |
|
|
Propylhydroxy benzoate (E216) |
0.57 mg |
|
For a full list of excipients, see section 6.1
3. Pharmaceutical Form
Oral Solution
A clear colourless banana flavoured solution.
4. Clinical Particulars
4.1 Therapeutic Indications
Symptoms of depressive illness. Relief of nocturnal enuresis in children.
4.2 Posology And Method Of Administration
Depression:
Adults: 1 x 25mg up to three times daily, increasing stepwise to 150-200mg. This should be reached by the end of the first week and maintained u
1. Name Of The Medicinal Product
Instanyl 50 micrograms nasal spray, solution in single-dose container
Instanyl 100 micrograms nasal spray, solution in single-dose container
Instanyl 200 micrograms nasal spray, solution in single-dose container
2. Qualitative And Quantitative Composition
Each nasal spray container contains one dose (100 microlitres) of fentanyl citrate equivalent to 50 micrograms fentanyl.
Each nasal spray container contains one dose (100 microlitres) of fentanyl citrate equivalent to 100 micrograms fentanyl.
Each nasal spray container contains one dose (100 microlitres) of fentanyl citrate equivalent to 200 micrograms fentanyl.
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Nasal spray, solution (nasal spray)
Clear, colourless solution.
4. Clinical Particulars
4.1 Therapeutic Indications
Instanyl is indicated for the management of breakthrough pain in adults already receiving maintenance opioid therapy for chronic cancer pain. Breakthrough pain is a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain.
Patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.
4.2 Posology And Method Of Administration
Treatment should be initiated by and remain under the supervision of a physician experienced in the management of opioid therapy in cancer patients. Physicians should keep in mind t
Influenza vaccine (split virion, inactivated) Ph. Eur.
Suspension for injection, pre-filled syringe
Read all of this leaflet carefully before you or your child is vaccinated.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This vaccine has been prescribed for you or your child. Do not pass it on to others.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
- 1. What Influenza vaccine (split virion, inactivated) is and what it is used for
- 2. Before you or your child use Influenza vaccine (split virion, inactivated)
- 3. How to use Influenza vaccine (split virion, inactivated)
- 4. Possible side effects
- 5. How to store Influenza vaccine (split virion, inactivated)
- 6. Further information
What Influenza Vaccine (Split Virion, Inactivated) Is And What It Is Used For
Influenza vaccine (split virion, inactivated) is a vaccine. This vaccine helps to protect you or your child against influenza (flu), particularly in people who run a high risk of associated complications.
The use of Influenza vaccine (split virion, inactivated) should be based on official recommendations.
When a person is given the vaccine Influenza vaccine (split virion, inactivated), the immune system (the body’s natural defence system) will produce its own protection (antibodies) against the disease. No
1. Name Of The Medicinal Product
100 mg: Inovelon 100 mg film-coated tablets.
200 mg: Inovelon 200 mg film-coated tablets.
400 mg: Inovelon 400 mg film-coated tablets.
2. Qualitative And Quantitative Composition
100 mg: Each film-coated tablet contains 100 mg rufinamide.
Excipient: 20 mg lactose monohydrate/film coated tablet.
200 mg: Each film-coated tablet contains 200 mg rufinamide.
Excipient: 40 mg lactose monohydrate/film coated tablet.
400 mg: Each film-coated tablet contains 400 mg rufinamide.
Excipient: 80 mg lactose monohydrate/film coated tablet.
For a full list of excipients, see section 6.1.
3. Pharmaceutical Form
Film-coated tablets.
100 mg: Pink, 'ovaloid', slightly convex, scored on both sides, embossed 'Ş261' on one side and blank on the other side.
200 mg: Pink, 'ovaloid', slightly convex, scored on both sides, embossed 'Ş262' on one side and blank on the other side.
400 mg: Pink, 'ovaloid', slightly convex, scored on both sides, embossed 'Ş263' on one side and blank on the other side.
The tablets can be divided into equal halves.
4. Clinical Particulars
4.1 Therapeutic Indications
Inovelon is indicated as adjunctive therapy in the treatment of seizures associated with Lennox
4.2 Posology And Method Of Administration
Treatment with Inovelon should be initiated by a physician specialised in paediatrics or neurology with experience in the treatment of epilepsy.
Inovelon is for oral use. It should be taken twice daily with water in the morning and in the evening, in two equally divided
1. Name Of The Medicinal Product
Infanrix-IPV, suspension for injection in pre-filled syringe
Diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed)
2. Qualitative And Quantitative Composition
|
One dose (0.5 ml) contains: |
|
| Diphtheria toxoid1 | not less than 30 IU |
| Tetanus toxoid1 | not less than 40 IU |
|
Bordetella pertussis antigens |
|
| Pertussis toxoid1 | 25 micrograms |
| Filamentous Haemagglutinin1 | 25 micrograms |
| Pertactin1 | 8 micrograms |
|
Poliovirus (inactivated)2 |
|
|
type 1 (Mahoney strain) |
40 D-antigen unit |
imuvac
Imuvac 2009/2010, suspension for injection in prefilled syringe
Influenza vaccine (surface antigen, inactivated)
Read all of this leaflet carefully before you or your child is vaccinated.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This vaccine has been prescribed for you or your child. Do not pass it on to others.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet
- 1 WHAT IMUVAC IS AND WHAT IT IS USED FOR
- 2 BEFORE YOU OR YOUR CHILD USE IMUVAC
- 3 HOW TO USE IMUVAC
- 4 POSSIBLE SIDE EFFECTS
- 5 HOW TO STORE IMUVAC
- 6 FURTHER INFORMATION
What Imuvac Is And What It Is Used For
Imuvac is a vaccine. This vaccine helps to protect you or your child against influenza (flu), particularly in subjects who run a high risk of associated complications. The use of Imuvac should be based on official recommendations.
When a person is given the vaccine Imuvac, the immune system (the body’s natural defence system) will produce its own protection (antibodies) against the disease. None of the ingredients in the vaccine can cause flu.
Flu is a disease that can spread rapidly and is caused by different types of strains that can change every year. Therefore, this is why you might need to be vaccinated every year. The great
Inovelon 100 mg film-coated tablets
Inovelon 200 mg film-coated tablets
Inovelon 400 mg film-coated tablets
Rufinamide
Read all of this leaflet carefully before you start taking this medicine
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
- 1. What Inovelon is and what it is used for
- 2. Before you take Inovelon
- 3. How to take Inovelon
- 4. Possible side effects
- 5. How to store Inovelon
- 6. Further information
What Inovelon Is And What It Is Used For
Inovelon contains rufinamide, which is an antiepileptic medicine. It is used to treat seizures associated with Lennox-Gastaut syndrome.
Before You Take Inovelon
Do not take Inovelon
- if you are allergic (hypersensitive) to rufinamide or any of the other ingredients of Inovelon and triazole derivatives.
Take special care with Inovelon
- if you suffer fr
Isotard XL Tablets
Isosorbide mononitrate (25, 40, 50 or 60mg)
Read all of this leaflet carefully before you start taking this medicine
- Keep this leaflet. You may need to read it again.
- If you have further questions, please ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What Isotard XL is and what it is used for
2. Before you take Isotard XL
3. How to take Isotard XL
4. Possible side effects
5. How to store Isotard XL
6. Further information
What Isotard XL is and what it is used for
Isotard XL modified release tablets are used to prevent attacks of angina (chest pain).
Isotard XL works by opening up blood vessels and reducing the pain.
Before you take Isotard XL
Do not take Isotard XL if:
- you are allergic (hypersensitive) to isosorbide-5-mononitrate or any of the other ingredients in Isotard XL modified release tablets (see Section 6 Further Information)
- you recently had a stroke or have a history of stroke
- you are taking sildenafil or similar products e.g. Viagra for male erectile dysfunction
- you have problems with your heart or circulation
- you have a lack of iron in your blood
- you suffer from closed angle glaucoma (high pressure in the eye)
- you have low blood pressure